Cargando…
The oncogenic fusion protein TAZ::CAMTA1 promotes genomic instability and senescence through hypertranscription
TAZ::CAMTA1 is a fusion protein found in over 90% of Epithelioid Hemangioendothelioma (EHE), a rare vascular sarcoma with an unpredictable disease course. To date, how TAZ::CAMTA1 initiates tumour formation remains unexplained. To study the oncogenic mechanism leading to EHE initiation, we developed...
Autores principales: | Neil, Emily, Paredes, Roberto, Pooley, Oscar, Rubin, Brian, Kouskoff, Valerie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657451/ https://www.ncbi.nlm.nih.gov/pubmed/37980390 http://dx.doi.org/10.1038/s42003-023-05540-4 |
Ejemplares similares
-
Unraveling the Biology of Epithelioid Hemangioendothelioma, a TAZ–CAMTA1 Fusion Driven Sarcoma
por: Seavey, Caleb N., et al.
Publicado: (2022) -
WWTR1(TAZ)-CAMTA1 gene fusion is sufficient to dysregulate YAP/TAZ signaling and drive epithelioid hemangioendothelioma tumorigenesis
por: Seavey, Caleb N., et al.
Publicado: (2021) -
The TAZ-CAMTA1 Fusion Protein Promotes Tumorigenesis via Connective Tissue Growth Factor and Ras–MAPK Signaling in Epithelioid Hemangioendothelioma
por: Ma, Shuang, et al.
Publicado: (2022) -
Widespread hypertranscription in aggressive human cancers
por: Zatzman, Matthew, et al.
Publicado: (2022) -
TAZ-CAMTA1 and YAP-TFE3 alter the TAZ/YAP transcriptome by recruiting the ATAC histone acetyltransferase complex
por: Merritt, Nicole, et al.
Publicado: (2021)